Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.54 |
| ▸ | MAOB | P27338 | 4/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.44 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL268688 | 0.98 | MAOA (0.52) | MAOAMAOBOPRM1OPRL1GAA | |
| SCHEMBL4581280 | 0.98 | MAOA (0.52) | MAOAMAOBOPRM1OPRL1GAA | |
| SCHEMBL1588016 | 0.98 | MAOA (0.52) | MAOAMAOBOPRM1OPRL1GAA | |
| SCHEMBL156160 | 0.95 | MAOA (0.54) | MAOAMAOBOPRM1OPRL1GAA | |
| SCHEMBL9141601 | 0.87 | MAOA (0.52) | MAOAMAOBOPRM1OPRL1GAA | |
| SCHEMBL16029497 | 0.87 | MAOA (0.47) | MAOAMAOBOPRM1OPRL1GAA | |
| SCHEMBL21275411 | 0.87 | MAOA (0.47) | MAOAMAOBOPRM1OPRL1GAA | |
| SCHEMBL4896945 | 0.87 | GAA (0.52) | MAOAMAOBGAAALDH1A1POLB | |
| Formamide SCHEMBL28694742 | 0.86 | MAOA (0.47) | MAOAMAOBOPRM1OPRL1GAA | |
| SCHEMBL2864890 | 0.85 | MAOA (0.50) | MAOAMAOBOPRM1OPRL1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025037676-A1 | HYALURONIC ACID HYDROGEL HAVING SKIN WOUND HEALING EFFECT BY CONTINUOUSLY RELEASING DRUG, AND HYALURONIC ACID HYDROGEL CAPABLE OF CONTROLLING DRUG RELEASE BY MEANS OF LIGHT BY USING PHOTO-CLEAVABLE LINKER | 가천대학교 산학협력단 | 2025-02-20 | — | — | WO | claimed |
| CN-118271188-A | Aromatic amine type organic compound, application thereof and organic electroluminescent device | 北京鼎材科技有限公司 | 2024-07-02 | — | — | CN | claimed |
| WO-1999010359-A2 | LIPOSOMIC BASED SIALYL LEWIS X MIMETICS | NOVARTIS AG (CH) | 1999-03-04 | — | — | WO | claimed |
| WO-2025037676-A1 | HYALURONIC ACID HYDROGEL HAVING SKIN WOUND HEALING EFFECT BY CONTINUOUSLY RELEASING DRUG, AND HYALURONIC ACID HYDROGEL CAPABLE OF CONTROLLING DRUG RELEASE BY MEANS OF LIGHT BY USING PHOTO-CLEAVABLE LINKER | 가천대학교 산학협력단 | 2025-02-20 | — | — | WO | disclosed |
| CN-118271188-A | Aromatic amine type organic compound, application thereof and organic electroluminescent device | 北京鼎材科技有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-115703747-A | Organic compound having spirofluorene structure for light emitting device, organic electroluminescent device | 北京鼎材科技有限公司 | 2023-02-17 | — | — | CN | disclosed |
| CN-110499161-B | Liquid crystal compound, liquid crystal composition and liquid crystal display device | 石家庄诚志永华显示材料有限公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-110499161-B | Liquid crystal compound, liquid crystal composition and liquid crystal display device | 石家庄诚志永华显示材料有限公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-114349744-A | Light-emitting device and amine compound for light-emitting device | 三星显示有限公司 | 2022-04-15 | — | — | CN | disclosed |
| EP-3928360-A1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | Merck Patent GmbH (DE) | 2021-12-29 | — | — | EP | disclosed |
| EP-3802520-A1 | COMPOSITION FOR ORGANIC ELECTRONIC DEVICES | Merck Patent GmbH (DE) | 2021-04-14 | — | — | EP | disclosed |
| WO-1999010359-A2 | LIPOSOMIC BASED SIALYL LEWIS X MIMETICS | NOVARTIS AG (CH) | 1999-03-04 | — | — | WO | disclosed |
| EP-0740649-A1 | NITROXY GROUP-CONTAINING BENZYLAMINE DERIVATIVES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES, AS WELL AS INCREASED INTRA-OCULAR PRESSURE | Byk Nederland BV (NL) | 1996-11-06 | — | — | EP | disclosed |
| EP-0689435-A1 | USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE | BYK NEDERLAND BV (NL) | 1996-01-03 | — | — | EP | disclosed |
| WO-1995019952-A1 | NITROXY GROUP-CONTAINING BENZYLAMINE DERIVATIVES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES, AS WELL AS INCREASED INTRA-OCULAR PRESSURE | BYK NEDERLAND BV (NL) | 1995-07-27 | — | — | WO | disclosed |
| WO-1994021248-A1 | USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE | BYK NEDERLAND BV (NL) | 1994-09-29 | — | — | WO | disclosed |